<DOC>
	<DOCNO>NCT02172547</DOCNO>
	<brief_summary>Post marketing Surveillance gain insight effect therapy Spiriva® ( tiotropium bromide ) health-related quality life COPD patient stop smoke treatment obtain safety data regard adverse event .</brief_summary>
	<brief_title>Effect Spiriva® Health-related Quality Life Chronic Obstructive Pulmonary Disease ( COPD ) Patients Who Stopped Smoking During Treatment .</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Patients COPD Smoker start Patients present general specific contraindication list Patient Information Leaflet ( 'Gebrauchsinformation ' ) Basic Product Information ( 'Fachinformation ' )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>